Argonautica Private Wealth Management Inc. Acquires 1,307 Shares of Smith & Nephew plc (NYSE:SNN)

Argonautica Private Wealth Management Inc. increased its holdings in Smith & Nephew plc (NYSE:SNN) by 12.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,614 shares of the medical equipment provider’s stock after acquiring an additional 1,307 shares during the quarter. Argonautica Private Wealth Management Inc.’s holdings in Smith & Nephew were worth $285,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of the business. Principal Securities Inc. grew its holdings in shares of Smith & Nephew by 87.6% during the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 691 shares during the last quarter. R Squared Ltd bought a new position in Smith & Nephew in the 4th quarter valued at approximately $41,000. Hara Capital LLC boosted its stake in Smith & Nephew by 391.4% during the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider’s stock valued at $60,000 after purchasing an additional 1,957 shares during the last quarter. GAMMA Investing LLC boosted its stake in Smith & Nephew by 31.8% during the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock valued at $73,000 after purchasing an additional 718 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Smith & Nephew by 74.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider’s stock worth $94,000 after purchasing an additional 1,290 shares in the last quarter. 25.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Berenberg Bank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, StockNews.com downgraded Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 12th.

Smith & Nephew Trading Up 6.9 %

SNN stock opened at $28.09 on Wednesday. The firm has a fifty day moving average price of $25.11 and a 200 day moving average price of $27.22. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The firm has a market cap of $12.28 billion, a PE ratio of 13.01, a price-to-earnings-growth ratio of 1.26 and a beta of 0.84.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.